Ascenion’s partner institute, the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), has joined forces with the…

In 2017 many exceptional projects from our partners reached important milestones, amongst them potential diagnostics and therapeutics as well as…

The European Commission has granted approval for Amgen’s BLINCYTO® (blinatumomab) for the treatment of pediatric patients with certain forms of B cell…

Drug developer Berlin Cures announced the successful completion of its Phase 1 study of its lead candidate BC 007 for the treatment of cardiomyopathy.…

Ascenion’s portfolio company OMEICOS reported positive Phase I data for its lead candidate OMT-28, a small molecule with strong anti-arrhythmic and…

BioFIT is a partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life…

Phase I study initiated with candidate against multidrug-resistant germs 

6 June 2018, Munich – The Leibniz Institute for Natural Product Research…

In April, the members of the rapidly growing TechnologieAllianz e.V. teamed up with founders, investors, scientists and politicians for the 3rd…

This year’s BioVaria was the event in 2018 for early-stage, life-science European startups to connect with investors, with a record number of company…

Startup Awards go to OPSYON and LIfT Biosciences

26 April 2018, Munich, Germany – Over 250 innovative minds gathered in Munich on April 23-24 for the…

BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international…

Technology sneak peek from Ascenion: Five breakthrough life-science inventions

9 March 2018, Munich, Germany – On 23–24 April 2018, decision makers…

Don’t miss your chance to secure a spot at BioVaria on 23./24. April 2018 to pitch your company to leading investors and biopharmaceutical decision…

The 3rd TechnologieAllianz Annual Conference will focus on science start-ups and their importance for the future of the German economy. Prominent…

Eye-to-eye networking, acquiring deeper knowledge, sharing experiences, keeping informed about new developments – these are the aims of the TT…